IPA (ImmunoPrecise Antibodies) is based in Victoria, BC, Canada. It has raised $200M in total funding.
IPA (ImmunoPrecise Antibodies) funding overview
IPA (ImmunoPrecise Antibodies) is based in Victoria, BC, Canada. IPA (ImmunoPrecise Antibodies) has raised $200M in total disclosed funding. That places its disclosed total in the $100M–$250M range.
IPA (ImmunoPrecise Antibodies) at a glance
Total raised
$200M
Headquarters
Victoria, BC, Canada
Frequently asked about IPA (ImmunoPrecise Antibodies) funding
How much has IPA (ImmunoPrecise Antibodies) raised?
IPA (ImmunoPrecise Antibodies) has raised $200M in total disclosed funding across the rounds on record.
Who has invested in IPA (ImmunoPrecise Antibodies)?
No investors are named on the public record for IPA (ImmunoPrecise Antibodies) yet.
What was the latest IPA (ImmunoPrecise Antibodies) funding round?
No round stage has been disclosed for IPA (ImmunoPrecise Antibodies).
Where is IPA (ImmunoPrecise Antibodies) based?
IPA (ImmunoPrecise Antibodies) is based in Victoria, BC, Canada.
Every IPA (ImmunoPrecise Antibodies) figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Victoria at a similar stage.
Companies related to IPA (ImmunoPrecise Antibodies) (39)
